Combined VEGFR and MAPK pathway inhibition in angiosarcoma

Angiosarcoma is an aggressive malignancy of endothelial cells that carries a high mortality rate. Cytotoxic chemotherapy can elicit clinical responses, but the duration of response is limited. Sequencing reveals multiple mutations in angiogenesis pathways in angiosarcomas, particularly in vascular e...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Wagner, Michael J., Lyons, Yasmin A., Siedel, Jean H., Dood, Robert, Nagaraja, Archana S., Haemmerle, Monika, Mangala, Lingegowda S., Chanana, Pritha, Lazar, Alexander J., Wang, Wei-Lien, Ravi, Vinod, Holland, Eric C., Sood, Anil K.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8087824/
https://ncbi.nlm.nih.gov/pubmed/33931674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-88703-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados